Trial intelligence / Profile preview

FlutiForm in severe persistent asthma

NCT00734318Phase 3Completed

Sponsor
Mundipharma
Start
Sep 2008
Primary completion
Jun 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of fluticasone propionate + formoterol in bronchial asthma, sponsored by Mundipharma. Started Sep 2008; status: completed.

02

Drugs

fluticasone propionate + formoterol
03

Conditions

bronchial asthma

Beyond the preview

Go deeper on NCT00734318.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00734318.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call